Reviewer: WANG Xian-ming, Literature Co-worker: XIAO Yu. The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 145-148. DOI: 10.12019/j.issn.1671-5144.2016.03.007
|
Citation:
|
Reviewer: WANG Xian-ming, Literature Co-worker: XIAO Yu. The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 145-148. DOI: 10.12019/j.issn.1671-5144.2016.03.007
|
Reviewer: WANG Xian-ming, Literature Co-worker: XIAO Yu. The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 145-148. DOI: 10.12019/j.issn.1671-5144.2016.03.007
|
Citation:
|
Reviewer: WANG Xian-ming, Literature Co-worker: XIAO Yu. The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 145-148. DOI: 10.12019/j.issn.1671-5144.2016.03.007
|
DownLoad: